Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Biogen (BIIB) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 47 quarters since 2010. Compare with BIIB stock chart to see long term trends.

BIIB Stock Compared to Quarterly

BIIB Income Statement

Revenue, Net:2778900000
Revenue Per Share:18.78
Cost of Goods & Services Sold:511800000
Selling, General & Admin Expense:654100000
Research & Development Expense:702400000
Total Operating Expenses:1984900000
Operating Income:794000000
Income Taxes:-25900000
Net Income:329200000
Earnings Per Share, Basic:2.22
Shares Outstanding, Basic Avg:148000000

BIIB Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:133200000
Change in Accounts Receiveable:53700000
Net Cash from Operations:805300000
Repurchases/Buybacks Common Stock:750000000
Net Cash from Financing Activities:-746500000
Property, Plant & Equipment Purchases:42000000
Net Cash from Investing Activities:-233600000
Net Change in Cash & Equivalents:-174800000

BIIB Balance Sheet

Cash and Cash Equivalents:1541800000
Short-Term Investments:null
Accounts Receivable, Net:1723000000
Inventories:1347900000
Total Current Assets:7162300000
Property, Plant & Equipment, Net:3410700000
Total Assets:23806700000
Accounts Payable:427900000
Total Short-Term Liabilities:4211600000
Total Liabilities:12925000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Primecap Management Co/Ca/
16,258,915 sh
-199,591 sh
-1%
$4,601,110
-$1,097,977
Blackrock Inc.
13,896,253 sh
689,662 sh
5%
$3,932,503
-$640,544
Vanguard Group Inc
11,691,876 sh
-61,457 sh
-1%
$3,308,684
-$761,143
State Street Corp
6,903,536 sh
223,496 sh
3%
$1,953,632
-$359,465
JPMorgan Chase & Co
5,605,297 sh
250,531 sh
5%
$1,586,243
-$267,952
Wellington Management Group Llp
5,577,720 sh
-24,141 sh
0%
$1,578,439
-$361,317
Clearbridge Investments, LLC
3,363,927 sh
-201,185 sh
-6%
$951,958
-$282,533
Geode Capital Management, LLC
2,775,266 sh
-118,484 sh
-4%
$783,496
-$216,599
Price T Rowe Associates Inc /Md/
1,784,136 sh
171,573 sh
11%
$504,893
-$53,489
Northern Trust Corp
1,758,890 sh
-308,649 sh
-15%
$497,749
-$218,177
Bank Of New York Mellon Corp
1,609,799 sh
-156,033 sh
-9%
$455,556
-$155,898
Legal & General Group Plc
1,406,196 sh
20,504 sh
1%
$397,940
-$81,890
Deutsche Bank Ag\
1,381,482 sh
1,381,470 sh
11512200%
$390,947
$390,943
Susquehanna International Group, Llp
Put options for 1,356,400 sh
1,356,400 sh
NEW
$383,847
$383,847
UBS Asset Management Americas Inc
1,244,986 sh
106,513 sh
9%
$352,318,590
-$41,900,457
FMR LLC
1,177,553 sh
-174,665 sh
-13%
$333,235
-$134,998
American Century Companies Inc
1,138,819 sh
-103,224 sh
-8%
$322,275
-$107,807
Dimensional Fund Advisors LP
1,130,190 sh
-57,498 sh
-5%
$319,872
-$91,381
Susquehanna International Group, Llp
Call options for 1,033,300 sh
1,033,300 sh
NEW
$292,413
$292,413
Invesco Ltd.
990,579 sh
-52,879 sh
-5%
$280,324
-$80,994

Data imported from Biogen Inc SEC filings. Check original filings before making any investment decision.